Angiogenesis: New Opportunities & Solutions for Drug Development

Venue: Hyatt Regency Cambridge

Location: Cambridge, Massachusetts, United States

Event Date/Time: Sep 29, 2003 End Date/Time: Sep 30, 2003
Report as Spam

Description

SPECIAL KEYNOTE PRESENTATION:

"The Future of Therapeutics: From DNA to Angiogenesis"

James D. Watson
President
COLD SPRING HARBOR LABORATORIES


Angiogenesis:

The therapeutic application of angiogenesis inhibitors has hit a major crossroad in development. After more than a decade of discovery and drug development, antiangiogenic agents have now shown efficacy in late stage clinical trials. This meeting will showcase both new and promising antiangiogenic therapeutic agents, present work on the current development of agents showing the greatest clinical potential, and discuss new challenges in successful drug development in this exciting field.

Presentations By:

Aeterna Laboratories
Amgen
The Angiogenesis Clinic
The Angiogenesis Foundation
Attenuon Pharma
Celgene
DOBI Systems
Genentech
ImClone Systems
M.D. Anderson Cancer Center
MedImmune
National Institutes of Health
Novartis
Peregrine Pharmaceuticals
Progen Industries
Sherris Pharma Partners
University of Oklahoma
Vanderbilt University
Zygogen

Venue